Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization.
Esteban Fernández A, Recio Mayoral A, González Franco A, Núñez Villota J, Mirabet S, Rubio Gracia J, González Costello J, Bonilla Palomas JL, Escobar Cervantes C. Esteban Fernández A, et al. Among authors: nunez villota j. Expert Opin Pharmacother. 2023 Apr;24(6):705-713. doi: 10.1080/14656566.2023.2195540. Epub 2023 Mar 31. Expert Opin Pharmacother. 2023. PMID: 36961877 Review.
Identifying the patient with heart failure to be treated with vericiguat.
Escobar Cervantes C, Esteban Fernández A, Recio Mayoral A, Mirabet S, González Costello J, Rubio Gracia J, Núñez Villota J, González Franco Á, Bonilla Palomas JL. Escobar Cervantes C, et al. Among authors: nunez villota j. Curr Med Res Opin. 2023 May;39(5):661-669. doi: 10.1080/03007995.2023.2189857. Epub 2023 Mar 23. Curr Med Res Opin. 2023. PMID: 36897009 Review.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Li J, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Varin C, Honarpour N, Abbasi SA, Malik FI, Kurtz CE; GALACTIC-HF Investigators. Teerlink JR, et al. N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33185990 Free article. Clinical Trial.
Serum potassium dynamics during acute heart failure hospitalization.
Caravaca Perez P, González-Juanatey JR, Nuche J, Morán Fernández L, Lora Pablos D, Alvarez-García J, Bascompte Claret R, Martínez Selles M, Vázquez García R, Martínez Dolz L, Cobo-Marcos M, Pascual Figal D, Crespo-Leiro MG, Nuñez Villota J, Cinca Cuscullola J, Delgado JF. Caravaca Perez P, et al. Among authors: nunez villota j. Clin Res Cardiol. 2022 Apr;111(4):368-379. doi: 10.1007/s00392-020-01753-3. Epub 2020 Oct 17. Clin Res Cardiol. 2022. PMID: 33070219 Free article.
Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
SEC Working Group for the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and SEC Guidelines Committee. SEC Working Group for the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and SEC Guidelines Committee. Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):458-465. doi: 10.1016/j.rec.2021.11.023. Epub 2022 Feb 18. Rev Esp Cardiol (Engl Ed). 2022. PMID: 35190290 English, Spanish. No abstract available.
[Red cell distribution width and mortality risk in acute heart failure patients].
Olivares Jara M, Santas Olmeda E, Miñana Escrivà G, Palau Sampio P, Merlos Díaz P, Sanchis Forés J, Núñez Villota J. Olivares Jara M, et al. Among authors: nunez villota j. Med Clin (Barc). 2013 May 13;140(10):433-8. doi: 10.1016/j.medcli.2012.09.044. Epub 2013 Jan 18. Med Clin (Barc). 2013. PMID: 23337456 Spanish.
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
Amat-Santos IJ, Sánchez-Luna JP, Abu-Assi E, Melendo-Viu M, Cruz-Gonzalez I, Nombela-Franco L, Muñoz-Garcí AJ, Blas SG, de la Torre Hernandez JM, Romaguera R, Sánchez-Recalde Á, Diez-Gil JL, Lopez-Otero D, Gheorge L, Ibáñez B, Iñiguez-Romo A, Raposeiras-Roubín S; Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) Investigators. Amat-Santos IJ, et al. Eur J Heart Fail. 2022 Mar;24(3):581-588. doi: 10.1002/ejhf.2370. Epub 2021 Nov 9. Eur J Heart Fail. 2022. PMID: 34693613 Free article. Clinical Trial.
32 results